Frontal fibrosing alopecia: follow-up of a brazilian group

Kusano, Leticia Dalla Costa; Mulinari‐Brenner, Fabiane

doi:10.1590/abd1806-4841.20197941

Cited by 1 publication

(2 citation statements)

References 6 publications

(7 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We used hydroxychloroquine and 5-alpha-reductase inhibitors similarly to Chileans18 and Secchin in Brazil, 17 but the former less frequently and the latter more frequently than reported in Valesky et al, 4 and Kusano in Brazil. 21 In our series, the use of topical corticosteroids and intralesional infiltration of corticosteroids was lower as compared with most other studies. 4 This may reflect the current fear of atrophy with injectable corticosteroids in Brazil.…”

Section: Discussioncontrasting

confidence: 58%

“…As for comorbidities, hypothyroidism was common among patients with FFA, with a lower prevalence than in other studies, 4,19 but similar to Brazilian studies. 17,21 In the authors experience, patients who were treated for FFA with doxycycline, hydroxychloroquine or finasteride had a slightly better control of the symptoms and clinical signs, such as positive pull test and pruritus, but progression seems to have its natural way and is limited to the natural history of the disease, which is still unknown. 7 Loss of body hair did not seem to be reversed or affected by treatment.…”

Section: Discussionmentioning

confidence: 98%

See 1 more Smart Citation

Clinical Characteristics of Frontal Fibrosing Alopecia in Brazil: A Series of 59 Patients

Rocha

Contin

Kakizaki

et al. 2020

SPDV

View full text Add to dashboard Cite

Introduction: Clinical characteristics of frontal fibrosing alopecia (FFA) have been studied since its description in 1994 in Europe, North America and Australia, and the present study is the largest on FFA features in Latin America. Methods: This study, through questionnaire and medical records, describes characteristics of a Brazilian population of 59 patients with FFA, concerning clinical forms, individual features and use of cosmetic products. Results: Mean patients’ age was 58.4 years (range 35-84y). Duration of disease varied from six months to 20y (median 5y). Most women were postmenopausal (83.1%) and non-smokers (83.1%). Five percent had at least one associated autoimmune disease, most commonly hypothyroidism (13.6%). Six of 40 patients (15%) had lichen planus pigmentosus and ten had facial papules (25%). Eyebrow alopecia occurred in 50 (84.7%), and body hair loss in 47 (79.7%). Facial papules were more prevalent in premenopausal women. Conclusion: Studying FFA epide- miology may help understanding the pathophysiology of this epidemic disease and this study highlights similarities and differences to previously published studies in FFA, such as greater frequency in postmenopausal women, association with hypothyroidism and facial irritation with cosmetic products.

show abstract